Delay in Cancer Diagnosis During the Era of the Coronavirus Disease 2019 Pandemic: Learning lessons
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Cancer is one of the leading causes of mortality worldwide and was responsible for an estimated 9.6 million deaths in 2018, with the majority (70%) occurring in low- and middle-income countries (LMICs).1 Furthermore, cancer survival tends to be poor in LMICs, most likely due to delays in cancer diagnosis, limited access to resources and a lack of national cancer screening programmes.2 As such, the number of cancer-related deaths can be reduced if patients are diagnosed and treated early.1 Delay in cancer diagnosis can occur at any point along the diagnostic spectrum, from the first observation of symptoms to the start of treatment and are typically categorised within one of the three time intervals: patient, primary care and secondary care intervals.